MDI market eyes promising future

The medical device integration (MDI) market appears to have secured a promising future in the healthcare industry, with a majority of U.S. hospitals expected to purchase new MDI solutions, according to a new CapSite report released on Thursday. 

The 2012 U.S. Medical Device Integration (MDI) Study includes insight from more than 300 hospitals and vendors across the country, speaking to primary drivers behind MDI investment and significant product attributes. 

More than 54 percent of U.S. hospitals plan to purchase new MDI solutions, and 40 percent of hospitals cite “quality improvements” as the primary investment driver. 

[See also: Medical device industry feeling ill over SCOTUS healthcare ruling.]

Valued at $105.8 billion in 2011 by business intelligence firm Espicom, the medical device market has established itself as a lucrative player in the healthcare field. 

The MDI study is the most recent in a series of CapSite strategic industry reports focused on assessing the impact of the HITECH Act of 2009. 

“Our study clearly shows that the MDI market has been very active over the past two years as provider organizations have made investments to connect their electronic health records with a variety of medical devices across their organization,” says CapSite senior vice president and general manager, Gino Johnson.

“Additionally, we expect the adoption of MDI solutions to continue to accelerate over the next two years as more than half of U.S. hospitals plan to purchase new MDI solutions,” said Johnson.

[See also: CapSite: Providers reevaluating teleradiology services, hospitals replacing PACS.]

Vendor Market Share coverage includes: 
Capsule, Cerner, CPSI, Draeger, Epic, Fukuda Denshi, GE, Healthland, HMS, iSirona, McKesson, Meditech, Mindray, Nihon Kohden, Nuvon, Siemens, Spacelabs and Welch Allyn.